| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 06/24/2004 | WO2004053110A1 Microorganism producing 5'-xanthylic acid |
| 06/24/2004 | WO2004053109A1 Microorganism producing 5'xanthylic acid |
| 06/24/2004 | WO2004053108A1 Protein fraction of barley spent grains as a medium for growth, sporulation and selection of actinomycetes and related bacteria |
| 06/24/2004 | WO2004053105A2 Direct snp detection with unamplified dna |
| 06/24/2004 | WO2004052462A1 Composition comprising lactobacilli or bifidobacteria and use thereof |
| 06/24/2004 | WO2004052297A2 TREATMENT OF HSV-RELATED PATHOLOGIES USING ssDNA |
| 06/24/2004 | WO2004052276A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/24/2004 | WO2004008838A3 Method for processing cereal material |
| 06/24/2004 | WO2004005474A3 A robust, inducible cardiac preferred expression system for transgenesis |
| 06/24/2004 | WO2004003513A3 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 06/24/2004 | WO2003097795A3 Constitutively translocating cell line |
| 06/24/2004 | WO2003093461A8 Genomic library of cyanophage s-2l and functional analysis |
| 06/24/2004 | WO2003027264A3 Coisogenic eukaryotic cell collections |
| 06/24/2004 | WO2003016473A3 Bovine leptin protein, antisense and antibody |
| 06/24/2004 | WO2003008560A8 A novel g protein-coupled receptor, gave8 |
| 06/24/2004 | WO2002095055A3 Compositions and methods for use in isolation of nucleic acid molecules |
| 06/24/2004 | WO2002086075A3 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 06/24/2004 | WO2001066563A8 T1r taste receptors and genes encoding same |
| 06/24/2004 | US20040122215 Human Ependymin |
| 06/24/2004 | US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals |
| 06/24/2004 | US20040121447 Method and apparatus for concentrating an aqueous suspension of microalgae |
| 06/24/2004 | US20040121446 Induction of gene expression using a high concentration sugar mixture |
| 06/24/2004 | US20040121445 Cell cultures |
| 06/24/2004 | US20040121439 Enzymes involved in squalene metabolism |
| 06/24/2004 | US20040121433 P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 06/24/2004 | US20040121431 Polypeptide having alpha-isomaltosyl-transferase activity |
| 06/24/2004 | US20040121428 Transgenic corynebacterium comprising and expressing fructose phosphotransferase to use in preparation of glutamic acid and lysine; enhancing animal feeds, medicines, nutrients and cosmetics |
| 06/24/2004 | US20040121425 having higher activity on penicillin G; phenylacetyl-7-aminodeacetoxycephalosporanic acid (7-ADCA); genetic engineering |
| 06/24/2004 | US20040121397 Using prostate tissue messenger RNA to detect, diagnose, classify, monitor, prognosticate, prevent or treat cell proliferative disorders of urogenital system |
| 06/24/2004 | US20040121387 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/24/2004 | US20040121384 Identifying defects in protein tyrosine phosphatase gene and diagnosing and treating leukemic blood disorder |
| 06/24/2004 | US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders |
| 06/24/2004 | US20040121370 Novel composition and methods for the treatment of immune related diseases |
| 06/24/2004 | US20040121347 Isolation and expression of a gene for a nitrilase from Acidovorax facilis 72W |
| 06/24/2004 | US20040121345 Identification of a human n-terminal acetyltransferase gene |
| 06/24/2004 | US20040120970 vaccine is for administration in the submucosa of the labiae is an attenuated form of a horse pathogenic bacterium |
| 06/24/2004 | US20040120945 Cell surface molecule mediating cell adhesion and signal transmission |
| 06/24/2004 | US20040118759 Method for water denitrification |
| 06/24/2004 | CA2508359A1 Direct snp detection with unamplified dna |
| 06/24/2004 | CA2508204A1 Treatment of hsv-related pathologies using ssdna |
| 06/24/2004 | CA2507592A1 Magnetism based rapid cell separation |
| 06/23/2004 | EP1431391A2 Rantes mutants and therapeutic applications thereof |
| 06/23/2004 | EP1431388A2 A method for direct cloning of nuclease genes in E.Coli |
| 06/23/2004 | EP1430152A2 Gene and protein relating to hepatocellular carcinoma |
| 06/23/2004 | EP1430139A2 Process for the preparation of d-pantothenic acid and/or its salts |
| 06/23/2004 | EP1430130A2 Nucleic acid-associated proteins |
| 06/23/2004 | EP1430129A2 Asip-related proteins |
| 06/23/2004 | EP1430126A1 Dna sequences for human angiogenesis genes |
| 06/23/2004 | EP1430125A2 Sperm-specific cation channel, and uses therefor |
| 06/23/2004 | EP1430124A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 06/23/2004 | EP1430118A2 A gene encoding cyclododecanone monooxygenase |
| 06/23/2004 | EP1430117A2 Plasticized hydrophilic glasses for improved stabilization of biological agents |
| 06/23/2004 | EP1430110A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids and encodingthe antigens, and methods of use. |
| 06/23/2004 | EP1430109A2 Cultivation of mycobacteria |
| 06/23/2004 | EP1430083A2 T1r taste receptors and genes encoding same |
| 06/23/2004 | EP1430079A1 Fluorescent proteins |
| 06/23/2004 | EP1430078A2 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production |
| 06/23/2004 | EP1429806A2 Extracellular massengers |
| 06/23/2004 | EP1429650A2 Alternatively spliced circulating tissue factor |
| 06/23/2004 | EP1274698B1 Percyquinnin, a process for its production and its use as a pharmaceutical |
| 06/23/2004 | EP1208213B1 Method for production of proteins in host cells involving the use of chaperonins |
| 06/23/2004 | EP1068323B1 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 06/23/2004 | EP0772676B2 Method of control of microorganism growth process |
| 06/23/2004 | EP0646176B1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 06/23/2004 | CN1507493A Biosynthetic genes for butenyl-spinosyn insecticide production |
| 06/23/2004 | CN1507492A P18A betar P gene and P18A beta r p protein, novel gene/protein (P60 TRP) interacting therewith to inhibit cell death and cell death promoter |
| 06/23/2004 | CN1507490A Promoters |
| 06/23/2004 | CN1507489A Microorganism having ability to convert sterol into androst-4-ene-3,17-di-one/androsta-1,4-diene-3,17-dione and preparation method and use thereof |
| 06/23/2004 | CN1507452A Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 06/23/2004 | CN1506464A Microbial colong and bittern conposition for making strong-smelling preserved bean curd and strong-smelling preserved bean curd making process |
| 06/23/2004 | CN1506460A Method and kit for separating cell particle from sample |
| 06/23/2004 | CN1506457A Production process of mycosis-resisting rice variety |
| 06/23/2004 | CN1506455A Endophytic Bacillus subtilis and its prepn |
| 06/23/2004 | CN1506454A Saccharomycetes containing large-scale salmon growth factor |
| 06/23/2004 | CN1506453A Bacteria-free active culture liquid preparing process and apparatus |
| 06/23/2004 | CN1506336A Microbial nitrogen fertilizer modified in plasma environment |
| 06/23/2004 | CN1506110A Application of Bulgaria inquinans or its mycelium in preparing medicine |
| 06/23/2004 | CN1154845C Biodetectors targeted to specific ligands |
| 06/23/2004 | CN1154744C Retroviral vectors that containing none of viral coding sequences |
| 06/23/2004 | CN1154742C Recombinant MVA virus, and the use thereof |
| 06/23/2004 | CN1154739C System for mass production of proteins or prptides by microorganisms of genus humicola |
| 06/23/2004 | CN1154736C Methods and compositions for secretion of heterologous polypeptides |
| 06/23/2004 | CN1154735C Mammalian gene encoding tolloid protein |
| 06/23/2004 | CN1154733C Improved heat-stable DNA polymerase |
| 06/23/2004 | CN1154730C Compounds and methods for diagnosis of tuberculosis |
| 06/23/2004 | CN1154729C Staphylokinase derivs |
| 06/23/2004 | CN1154727C Recombinant expression vector of human parathyroid hormone using phosphoribulokinase as fusion partner |
| 06/23/2004 | CN1154726C OB protein derivatives having prolonged half-life |
| 06/23/2004 | CN1154722C Biological synthetic gene II of boitin |
| 06/23/2004 | CN1154716C L-isoleucine-producing bacterium and method for preparing L-isoleucine through femrentation |
| 06/23/2004 | CN1154715C Microbial agricultural chemical |
| 06/22/2004 | US6753412 Human Eag2 |
| 06/22/2004 | US6753314 Protein-protein complexes and methods of using same |
| 06/22/2004 | US6753295 Plant activator, process for producing the same, activation method, activity promoter and method for applying the promoter |
| 06/22/2004 | US6753176 Genetic engineering; antiarthritic agents |
| 06/22/2004 | US6753175 Antiinflammatory agents; anticancer agents; cardiovascular disorders; genetic engineering; transgenic animals |
| 06/22/2004 | US6753170 Generation of acetic acid; obtain acetogenic bacteria, remove carbon dioxide from fermentation broth, incubate broth with solvent, continuously distill acetic acid from solvent |
| 06/22/2004 | US6753166 Nucleotide sequences coding polypeptides for use in the treatment of inflammatory and autoimmune diseases |
| 06/22/2004 | US6753149 For producing vaccines for the prevention or attenuation of infection by staphylococcus |
| 06/22/2004 | US6753136 Expressing preferential amino acid sequences on surface of viruses; obtain genetically engineered viruses, express amino acid sequences, moniltor viral coat for presence of preferential amino acid sequences |